Recent epidemiological data suggest that certain autoimmune diseases carry a small but measurable increase in the risk of specific cancers. In 2023, the American Journal of Medicine reported a 12% higher incidence of lymphoma among patients with long‑standing rheumatoid arthritis (RA) compared to the general population. At the same time, breakthroughs in immunotherapy are redefining how we harness immune surveillance to both control autoimmunity and target malignant cells. Understanding the autoimmune–cancer link is crucial for clinicians and patients alike to balance disease control with long‑term safety.

Positive ANA but “Normal” Labs Everywhere Else? Why You Aren’t “Crazy.”
You’re sitting at home, you open your patient portal, and there it is in bold letters: ANA Positive. Pattern: Speckled. If your first instinct was to open Google, you’ve likely seen scary terms like Lupus, Scleroderma, or Mixed Connective Tissue Disease. The “Portal Panic” is real. You have a positive result, a dozen questions, and a primary care doctor who tells you the soonest you can see a specialist is four months from now.
At Concierge Rheum, we believe that waiting four months for clarity is unacceptable. Let’s break down what that “Speckled” result actually means and why you shouldn’t panic just yet.
Key Takeaways
- The “Pre-Clinical” Window: Research shows that autoantibodies can show up in your blood years before clinical diseases like Rheumatoid Arthritis or Lupus develop.
- Systemic vs. Localized Inflammation: Common tests like CRP and ESR only measure systemic inflammation spilling into the bloodstream, easily missing localized tissue inflammation.
- Treating Symptoms, Not Spreadsheets: Rather than waiting for a “name-brand” diagnosis, Dr. Dhillon focuses on treating your actual symptoms—like fatigue, brain fog, or joint pain today.
- No “Wait and See”: Instead of waiting for organs to show distress, concierge patients get instant access and sub-serology testing that general labs miss.
It’s one of the most frustrating experiences in healthcare. You’re exhausted, your joints ache, and your ANA came back positive. You finally get to a doctor, expecting answers, only to be told: “Your inflammatory markers are low. Your kidney function is perfect. Your labs are normal. Let’s just wait and see.”
You leave the office feeling unheard, or worse, like your symptoms are “all in your head.”
At Concierge Rheum, Dr. Josh Dhillon knows that “normal” labs don’t always mean you are healthy. If you have a positive ANA but everything else looks fine on paper, here is what is actually happening in your body.
1. The "Pre-Clinical" Phase: Your Labs Haven't Caught Up Yet
During this “pre-clinical” phase, you may experience:
● Substantial fatigue
● “Brain fog”
● Transient joint pain
● Raynaud’s Phenomenon (fingers turning white or blue in the cold)
In a high-volume medical system, a doctor may not have the time to track these subtle changes. At Concierge Rheum, we view this as a critical window of opportunity to intervene with lifestyle, diet, and stress management before the “normal” labs turn “abnormal.”
2. Inflammation Isn't Always "Systemic"
Common tests like the CRP (C-Reactive Protein) or ESR (Sedimentation Rate) measure systemic inflammation—basically, inflammation that has spilled over into your entire bloodstream.
However, it is entirely possible to have localized inflammation in your joints or tissues that isn’t “loud” enough to trigger a high CRP result. This is why Dr. Dhillon uses specialized physical exams and patient history to look deeper than just a standard blood panel.
3. The "Healthy" ANA Positive
As we’ve discussed before, a segment of the population is “ANA-positive” but will never develop an autoimmune disease. However, the difference between a “healthy positive” and an “early-stage patient” cannot be determined in a 10-minute insurance-based visit.
It requires:
- Time: To listen to the nuance of your symptoms.
- Consistency: Having the same doctor follow your labs over time to spot trends.
- Clarity: Understanding the difference between total health and the mere absence of disease.
The Problem with the "Wait and See" Approach
What We Do Differently
- Perform Deep-Dive Diagnostics: Looking at sub-serologies and biomarkers that general labs often miss.
- Focus on Quality of Life:Treating your presenting symptoms, rather than waiting to establish a “name-brand” diagnosis. Due to the complexity in rheumatology, not every patient fits into a neat category of diagnosis (i.e. seronegative inflammatory arthritis)
- Provide Instant Access: When you feel a new symptom, you can reach Dr. Dhillon immediately—not in four months.
Stop waiting for your labs to "break" before you get help.
Frequently Asked Questions (FAQs)
During the pre-clinical phase—before a disease fully develops—you may experience substantial fatigue, "brain fog", transient joint pain, and Raynaud’s Phenomenon (where your fingers turn white or blue in the cold).
The traditional medical system is designed to treat crises, often sending you home until you get "sick enough" to treat if you don't meet a specific checklist. Instead of waiting for your labs to "break", you should seek deep-dive diagnostics that look at sub-serologies and biomarkers that general labs miss.





